Your session is about to expire
← Back to Search
Computer-Based Learning for Dementia Care in Prisons
N/A
Waitlist Available
Led By Susan Loeb
Research Sponsored by Klein Buendel, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up focus groups will conducted in year 1. the analysis will be completed in year 1 immediately following the conduct of the focus groups.
Awards & highlights
Study Summary
This trial will focus on creating computer-based learning modules to teach prison staff and inmates how to better care for prisoners with Alzheimer's Disease and Related Dementias.
Who is the study for?
This trial is for prison staff and inmates at participating prisons who are involved in caring for individuals with Alzheimer's Disease and Related Dementias (ADRD). Staff should manage ADRD care, and inmates must have caregiving experience. All participants must be able to speak, understand, and read English, as well as provide consent.Check my eligibility
What is being tested?
The study is testing an interactive e-learning program designed to improve dementia care within the prison system. It aims to educate both staff and inmate peer caregivers on how to better support those affected by ADRD through a computer-based learning module.See study design
What are the potential side effects?
Since this intervention involves educational material rather than medical treatment, traditional physical side effects are not applicable. However, users may experience stress or emotional discomfort while engaging with the content due to the sensitive nature of dementia care.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ focus groups will conducted in year 1. the analysis will be completed in year 1 immediately following the conduct of the focus groups.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~focus groups will conducted in year 1. the analysis will be completed in year 1 immediately following the conduct of the focus groups.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Focus Groups
System Usability Scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: Training PrototypeExperimental Treatment1 Intervention
Testing of 3 e-learning modules
Find a Location
Who is running the clinical trial?
Penn State UniversityOTHER
355 Previous Clinical Trials
125,709 Total Patients Enrolled
14 Trials studying Dementia
4,228 Patients Enrolled for Dementia
Klein Buendel, Inc.Lead Sponsor
38 Previous Clinical Trials
19,447 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,684 Previous Clinical Trials
28,025,789 Total Patients Enrolled
272 Trials studying Dementia
23,628,201 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Training Prototype
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this clinical experiment ongoing?
"The data appearing on clinicaltrials.gov indicates that the present medical trial is not seeking applicants. Initially posted on January 1st, 2023 and last edited November 8th, 2022; this research does not have any open slots currently available but 396 other studies are actively recruiting participants at this moment in time."
Answered by AI
Share this study with friends
Copy Link
Messenger